USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression

Abstract Background Intracellular membraneless organelles formed by liquid-liquid phase separation (LLPS) function in diverse physiological processes and have been linked to tumor-promoting properties. The nucleolus is one of the largest membraneless organelle formed through LLPS. Deubiquitylating e...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaoxuan Cheng, Zhiyuan Qiu, Ziyi Zhang, Yuxuan Li, Yue Zhu, Yuxin Zhou, Yinghui Yang, Yaowen Zhang, Dian Yang, Yingqiu Zhang, Han Liu, Zhaoxia Dai, Shu-Lan Sun, Shuyan Liu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-025-02059-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571483104215040
author Shaoxuan Cheng
Zhiyuan Qiu
Ziyi Zhang
Yuxuan Li
Yue Zhu
Yuxin Zhou
Yinghui Yang
Yaowen Zhang
Dian Yang
Yingqiu Zhang
Han Liu
Zhaoxia Dai
Shu-Lan Sun
Shuyan Liu
author_facet Shaoxuan Cheng
Zhiyuan Qiu
Ziyi Zhang
Yuxuan Li
Yue Zhu
Yuxin Zhou
Yinghui Yang
Yaowen Zhang
Dian Yang
Yingqiu Zhang
Han Liu
Zhaoxia Dai
Shu-Lan Sun
Shuyan Liu
author_sort Shaoxuan Cheng
collection DOAJ
description Abstract Background Intracellular membraneless organelles formed by liquid-liquid phase separation (LLPS) function in diverse physiological processes and have been linked to tumor-promoting properties. The nucleolus is one of the largest membraneless organelle formed through LLPS. Deubiquitylating enzymes (DUBs) emerge as novel therapeutic targets against human cancers. However, the nucleolar phase separation of DUBs and association with lung cancer development have remained incompletely investigated till now. Methods GFP-USP39 fusion proteins were analyzed for LLPS properties using immunofluorescence, fluorescence recovery after photobleaching (FRAP) and in vitro LLPS assays. Intrinsically-disordered regions of USP39 were analyzed by PhaSepDB database. Transcriptomic profiling, Western blot, RT-PCR and luciferase reporter assays were conducted to identify targets regulated by USP39. The effects of USP39 depletion on tumor progression were tested using doxycycline-inducible USP39 knockdown and rescue lung adenocarcinoma cells both in vitro and in vivo by performing MTT, colony formation, EdU staining, transwell and tumor xenograft model experiments. Results USP39 phase separates into nucleoli depending upon its N-terminal disordered region with amino acid residues 1-103. Lung cancer cell growth and migration were dramatically inhibited by USP39 knockdown, which was rescued by exogenous USP39 complementation. Moreover, knockdown of USP39 reduced oncogenic transcription effector GLI1 levels. Finally, USP39 downregulation restricted the formation of lung cancer xenografts in nude mice. Conclusions USP39 undergoes LLPS in the nucleolus and promotes tumor progression by regulating GLI1 expression. Downregulation of USP39 effectively suppressed lung cancer growth, and therefore targeting USP39 provides novel therapeutic strategy to treat lung cancer.
format Article
id doaj-art-e221652eaf76464ca9290cb681fafe3c
institution Kabale University
issn 1478-811X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj-art-e221652eaf76464ca9290cb681fafe3c2025-02-02T12:34:28ZengBMCCell Communication and Signaling1478-811X2025-01-0123111810.1186/s12964-025-02059-5USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expressionShaoxuan Cheng0Zhiyuan Qiu1Ziyi Zhang2Yuxuan Li3Yue Zhu4Yuxin Zhou5Yinghui Yang6Yaowen Zhang7Dian Yang8Yingqiu Zhang9Han Liu10Zhaoxia Dai11Shu-Lan Sun12Shuyan Liu13Institute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityInstitute of Cancer Stem Cell, Dalian Medical UniversityThe Second Department of Thoracic Medical Oncology, Second Hospital of Dalian Medical UniversityCentral Laboratory, Cancer Hospital, Cancer Hospital of China Medical University, Dalian University of Technology, Liaoning Cancer Hospital & InstituteInstitute of Cancer Stem Cell, Dalian Medical UniversityAbstract Background Intracellular membraneless organelles formed by liquid-liquid phase separation (LLPS) function in diverse physiological processes and have been linked to tumor-promoting properties. The nucleolus is one of the largest membraneless organelle formed through LLPS. Deubiquitylating enzymes (DUBs) emerge as novel therapeutic targets against human cancers. However, the nucleolar phase separation of DUBs and association with lung cancer development have remained incompletely investigated till now. Methods GFP-USP39 fusion proteins were analyzed for LLPS properties using immunofluorescence, fluorescence recovery after photobleaching (FRAP) and in vitro LLPS assays. Intrinsically-disordered regions of USP39 were analyzed by PhaSepDB database. Transcriptomic profiling, Western blot, RT-PCR and luciferase reporter assays were conducted to identify targets regulated by USP39. The effects of USP39 depletion on tumor progression were tested using doxycycline-inducible USP39 knockdown and rescue lung adenocarcinoma cells both in vitro and in vivo by performing MTT, colony formation, EdU staining, transwell and tumor xenograft model experiments. Results USP39 phase separates into nucleoli depending upon its N-terminal disordered region with amino acid residues 1-103. Lung cancer cell growth and migration were dramatically inhibited by USP39 knockdown, which was rescued by exogenous USP39 complementation. Moreover, knockdown of USP39 reduced oncogenic transcription effector GLI1 levels. Finally, USP39 downregulation restricted the formation of lung cancer xenografts in nude mice. Conclusions USP39 undergoes LLPS in the nucleolus and promotes tumor progression by regulating GLI1 expression. Downregulation of USP39 effectively suppressed lung cancer growth, and therefore targeting USP39 provides novel therapeutic strategy to treat lung cancer.https://doi.org/10.1186/s12964-025-02059-5LLPSNucleolusUSP39GLI1Lung adenocarcinoma
spellingShingle Shaoxuan Cheng
Zhiyuan Qiu
Ziyi Zhang
Yuxuan Li
Yue Zhu
Yuxin Zhou
Yinghui Yang
Yaowen Zhang
Dian Yang
Yingqiu Zhang
Han Liu
Zhaoxia Dai
Shu-Lan Sun
Shuyan Liu
USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
Cell Communication and Signaling
LLPS
Nucleolus
USP39
GLI1
Lung adenocarcinoma
title USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
title_full USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
title_fullStr USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
title_full_unstemmed USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
title_short USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
title_sort usp39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting gli1 expression
topic LLPS
Nucleolus
USP39
GLI1
Lung adenocarcinoma
url https://doi.org/10.1186/s12964-025-02059-5
work_keys_str_mv AT shaoxuancheng usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT zhiyuanqiu usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT ziyizhang usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT yuxuanli usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT yuezhu usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT yuxinzhou usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT yinghuiyang usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT yaowenzhang usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT dianyang usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT yingqiuzhang usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT hanliu usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT zhaoxiadai usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT shulansun usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression
AT shuyanliu usp39phaseseparatesintothenucleolusanddriveslungadenocarcinomaprogressionbypromotinggli1expression